Dina Scaglione

Dina Scaglione is an accomplished marketing professional with extensive experience in the biotechnology and healthcare industries. Currently serving as the Director of Oncology Marketing at Natera since August 2020, Dina spearheads the commercial launch of the Signatera assay, focusing on enhancing brand awareness and developing key opinion leader relationships. Previous roles include Director of Marketing at Agendia, where Dina managed global marketing activities for genomic profiling assays, and Director of Marketing at Ambry Genetics, responsible for go-to-market strategies for genetic testing solutions. Additional experience encompasses leadership positions at 46 Labs LLC, Aviir, Clarient, TeleCommunication Systems, HomeWord, and Maven Marketing, showcasing expertise in strategic marketing, branding, and communications. Dina holds a Bachelor of Arts degree in Journalism from California State University, Long Beach.